Abbott Laboratories SG&A Expense (Annual) Trends

Abbott Laboratories (ABT)

102.19 +0.45 (+0.44%) USD | NYSE | May 31, 16:00

102.16 -0.03 (-0.03%) Pre-Market: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 1984. Upgrade now.

Date	Value
December 31, 2023	10.95B
December 31, 2022	11.25B
December 31, 2021	11.32B
December 31, 2020	9.696B
December 31, 2019	9.765B
December 31, 2018	9.744B
December 31, 2017	9.182B
December 31, 2016	6.736B
December 31, 2015	6.785B
December 31, 2014	6.53B
December 31, 2013	6.372B
December 31, 2012	6.735B
December 31, 2011	7.365B
December 31, 2010	10.38B
December 31, 2009	8.406B
December 31, 2008	8.436B
December 31, 2007	7.408B
December 31, 2006	6.350B
December 31, 2005	5.496B
December 31, 2004	4.922B

Date	Value
December 31, 2003	4.808B
December 31, 2002	3.725B
December 31, 2001	3.735B
December 31, 2000	2.894B
December 31, 1999	2.857B
December 31, 1998	2.760B
December 31, 1997	2.696B
December 31, 1996	2.460B
December 31, 1995	2.231B
December 31, 1994	2.054B
December 31, 1993	1.988B
December 31, 1992	2.821B
December 31, 1991	2.180B
December 31, 1990	1.842B
December 31, 1989	1.602B
December 31, 1988	1.482B
December 31, 1987	1.280B
December 31, 1986	1.061B
December 31, 1985	928.20M
December 31, 1984	862.10M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

9.696B

Minimum

2020

11.32B

Maximum

2021

10.60B

Average

10.95B

Median

2023

SG&A Expense (Annual) Benchmarks